Lexie Lumen vs Resound Vivia 9 60S microRIE

The Lexie Lumen is a budget-priced OTC hearing aid that earned a B grade with a SoundScore of 3.5/5 in our lab testing, placing it in the top 60% of the OTC category. At $299, this behind-the-ear device uses disposable batteries and represents one of the more affordable entry points into amplification. In our standardized testing, the Lumen demonstrated notably strong feedback handling, scoring 5.0/5 in the tuned configuration—0.46 points above the category average. This excellent stability means users can expect minimal whistling during typical daily activities. Speech in noise performance scored 2.0/5, which is above the category average by 0.55 points, though still mixed in absolute terms. The device shows clear limitations in certain areas. Music streaming scored 0.0/5, falling 1.92 points below category average—prospective buyers who prioritize phone streaming for music or media should consider alternatives. Speech in quiet performance is also slightly below average at 2.5/5, a mixed result that may affect understanding in everyday conversation. The Lexie Lumen is best suited for budget-conscious first-time users who prioritize stable, feedback-free amplification over streaming capabilities. However, shoppers in this price range have several higher-performing alternatives available, including the Sony CRE-E10 and Lexie B2 Plus, both of which scored significantly higher in our testing.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.